Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells

Journal of Virology

Volumn 78, Issue 11, 2004, Pages 5820-5834

  Guerra, Susana ^a   López Fernández, Luis A ^a   Conde, Raquel ^a   Pascual Montano, Alberto ^a   Harshman, Keith ^a   Esteban, Mariano ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; GENE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC TRANSCRIPTION; HELA CELL; HISTONE FAMILY MEMBER GENE; HOST CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IL 15 GENE; IL 1A GENE; IL 6 GENE; IL 7 GENE; IL 8 GENE; IMMUNE RESPONSE; IMMUNOMODULATION; MODIFIED VACCINIA VIRUS ANKARA; NFKB GENE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; P50 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAC 1 GENE; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SIGNAL TRANSDUCTION; TRAF INTERACTING PROTEIN GENE; UNINDEXED SEQUENCE; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS STRAIN; WAS GENE; WASF1 GENE;

BLOTTING, NORTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINIA VIRUS;

EID: 2442638941     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.11.5820-5834.2004     Document Type: Article

References (43)

1. Altenburger, W., C.-P. Sütter, and J. Altenburger. 1989. Partial deletion of the human host range in the attenuated vaccinia virus MVA. Arch. Virol. 105:15-27.
2. Antonie, G., F., Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396.
3. Azimi, N., K. Brown, R. N. Bamford, Y. Tagaya, U. Siebenlist, and T. A. Waldmann. 1998. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc. Natl. Acad. Sci. USA 95:2452-2457.
4. Blanchard, T. J., A. Alcamí, P. Andrea, and G. L. Smith. 1998. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implication for use as a human vaccine. J. Gen. Virol. 79:1159-1167.
5. Bolt, G., K. Berg, and M. Blixenkrone-Moller. 2002. Measles virus-induced modulation of host-cell gene expression. J. Gen. Virol. 83:1157-1165.
6. Caron, E. 2002. Regulation of Wiskott-Aldrich syndrome protein and related molecules. Curr. Opin. Cell Biol. 14:82-87.
7. Carroll, M. W., and B. Moss. 1997. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238: 198-211.
8. Carroll, M. W., W. W. Overwijk, R. S. Chamberlain, S. A. Rosenberg, B. Moss, and N. P. Restifo. 1997. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine 15:387-394.
9. Chang, Y. E., and L. A. Laimins. 2000. Microarray analysis identifies interferon-inducible genes and stat-1 as major transcriptional target of human papillomavirus type 31. J. Virol. 74:4174-4182.
10. Chen, F., V. Castranova, X. Shi, and L. M. Demers. 1999. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45:7-17.
11. Drexler, I., K. Heller, B. Wahren, V. Erfle, and G. Sütter. 1998. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J. Gen. Virol. 79:347-352.
12. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
13. Frischknecht, F., V. Moreau, S. Rottger, I. Reckmann, C. Superti-Furga, and M. Way. 1999. Actin based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 404:1007-1011.
14. Gallego-Gómez, J. C., C. Risco, D. Rodriguez, P. Cabezas, S. Guerra, J. L. Carrascosa, and M. Esteban. 2003. Differences in virus-induced cell morphology and virus maturation between the WR and MVA strains of vaccinia virus. J. Virol. 77:10606-10622.
15. García de la Nava, J., D. Franco Santaella, J. Cuenca Alba, J. M. Carazo, O. Trelles, and A. Pascual-Montano. 2003. Engene: the processing and exploratory analysis of gene expression data. Bioinformatics 19:657-658.
16. Geiss, G. K., R. E. Bumgarner, M. C. An, A. B. Agy, A. B. van't Wout, E. Hammersmark, V. S. Carter, D. Upchurch, J. I. Mullins, and M. G. Katze. 2001. Large-scale monitoring of host gene expression during HIV-1 infection using cDNA microarrays. Virology 266:8-16.
17. Guerra, S., L. A. López-Fernandez, A. Pascual-Montano, M. Muñoz, K. Harshman, and M. Esteban. 2003. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77:6493-6506.
18. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifston. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
19. Hughes, T. R., M. J. Marton, A. R. Jones, C. J. Roberts, R. Stoughton, C. D. Armour, H. A. Bennett, E. Coffey, H. Dai, Y. D. He, M. J. Kidd, A. M. King, M. R. Meyer, D. Slade, P. Y. Lum, S. B. Stepaniants, D. D. Shoemaker, D. Gachotte, K. Chakraburtty, J. Simon, M. Bard, and S. H. Friend. 2000. Functional discovery via a compendium of expression profiles. Cell 102:109-126.
20. Jones, J. O., and A. M. Arvin. 2003. Microarray analysis of host cell gene transcription in response to Varicella-Zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J. Virol. 77: 1268-1280.
21. Keck, J. G., C. J. Baldick, Jr., and B. Moss. 1990. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell 61:801-809.
22. Kohonen, T. 1997. Self-organizing maps, 2nd ed. Springer-Verlag, Heidelberg, Germany.
23. Mahnel, H., and A. Mayr. 2002. Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA. Berl. Muench. Tieraerztl. Wochenschr. 107:253-256.
24. Mayr, A., H. Stickl, H. K. Muller, K. Danner, and H. Singer. 1978. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with parenteral vaccination and behaviour in organism with a debilitated defense mechanism. Zentbl. Bakteriol. B 167:375-390.
25. Meyer, H., G. Sutter, and A. Mayr. 1991. Mapping of deletions in the genome of highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72:1031-1038.
26. Miki, H., K. Minura, and T. Takenawa. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15: 5326-5335.
27. Moreau, V., F. Frischknecht, I. Reckmann, G. Superti-Furga, and M. Way. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2:441-448.
28. Moss, B., M. W. Carroll, L. S. Wyatt, J. R. Bennink, V. M. Hirsch, S. Golldstein, W. R. Elkins, W. Overwijk, R. Chamberlain, S. A. Rosenberg, and G. Sutter. 1996. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv. Exp. Med. Biol. 397:7-13.
29. Moss, B., and J. L. Shisler. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:59-66.
30. Nees, N., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
31. Oie, L. K., and D. Pickup. 2001. Cowpox and other members of the orthopoxvirus genus interfere with the regulation of NF-KB activation. Virology 288:175-187.
32. Quackenbush, J. 2002. Microarray data normalization and transformation. Nat. Genet. 32:496-501.
33. Ramirez, J. C., M. M. Gherardi, and M. Esteban. 2000. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol. 74:923-933.
34. Sancho, M. C., S. Schleich, G. Griffiths, and J. Krijnse-Locker. 2002. The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis. J. Virol. 76:8318-8334.
35. Schneider, J., S. C. Gilbert, T. J. Blanchard, T. Hanke, K. J. Robson, C. M. Hannan, M. Becker, R. Sinden, G. L. Smith, and A. V. S. Hill. 1998. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.
36. Sütter, G., and B. Moss. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89:10847-10851.
37. Sütter, G., L. S. Wyatt, P. L. Foley, J. R. Benninnk, and B. Moss. 1994. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12:1032-1040.
38. Symons, M., J. M. Derry, B. Karlak, S. Jiang, V. Lemahieu, F. McCormick, U. Francke, and A. Abo. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase Cdc42Hs, is implicated in actin polymerization. Cell 84:723-734.
39. Takenawa, T., and H. Miki. 2001. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J. Cell Sci. 114:1801-1809.
40. Tamayo, P., D. Slonim, J. Mesirov, Q. Zhu, E. Dmitrovsky, E. S. Lander, and T. R. Golub. 1999. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci USA 96:2907-2912.
41. +-T-cell lines. J. Virol. 77:1392-1402.
42. Wyatt, L. S., M. W. Carroll, C.-P. Czerny, M. Merchlinsky, J. R. Sisler, and B. Moss. 1998. Marker rescue of the host range restrictions defects of modified vaccinia virus Ankara. Virology 251:334-342.
43. Zhu, H., J. P. Cong, G. Mantora, T. Gineras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:14470-14475.